Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01219439 · ClinicalTrials.gov registry record

Evaluation of Discarded Laboratory Pathological Specimens and Media

A clinical trial of Serum and Non-viable Oocytes, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
10,000
Enrollment target
1
Study location

NCT01219439: Completed study of Serum and Non-viable Oocytes, sponsored by Reproductive Medicine Associates of New Jersey.

NCT01219439 is a study of Serum and Non-viable Oocytes that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01219439, a study of Serum and Non-viable Oocytes, has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The researchers propose to investigate the causes, incidence, and time-related events of chromosomal and physiologic abnormalities as they relate to patient diagnosis, fertility drugs utilized, and in vitro laboratory culture conditions.

Primary Outcome

To test, standardize and implement better methods for the freezing of ooyctes and sperm prior to these techniques being used in the clinical setting.

Study Locations (1)

New Jersey

  • Reproductive Medicine Assoicates of New Jersey - Basking Ridge

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2007-07
Est. Completion 2022-12

What the finished NCT01219439 record still lists

NCT01219439 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 7 conditions, with Serum appearing as the primary indexed condition, and to 0 interventions.

NCT01219439 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT01219439 about?

NCT01219439 is a clinical study titled "Evaluation of Discarded Laboratory Pathological Specimens and Media". The researchers propose to investigate the causes, incidence, and time-related events of chromosomal and physiologic abnormalities as they relate to patient diagnosis, fertility drugs utilized, and in vitro laboratory culture conditions.

What is the current status of trial NCT01219439?

This trial is currently completed. The enrollment target is 10,000 participants. The study started on 2007-07. Estimated completion is 2022-12.

What conditions does trial NCT01219439 study?

This clinical trial studies the following conditions: Serum, Non-viable Oocytes, Extra Spermatozoa, Seminal Fluid, Granulosa Cells.

Who is sponsoring clinical trial NCT01219439?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01219439 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Serum

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01219439, the US trial registry maintained by the National Library of Medicine. NCT01219439 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.